Glucan-immunostimulant, adjuvant, potential drug

doi:10.5306/wjco.v2.i2.115

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5049)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

466

HTML

4358

Figures (1-1)

225

Sum=5049

Feb 10, 2011 (publication date) through May 19, 2024

Times Cited of This Article

Times Cited (75)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Feb 10, 2011; 2(2): 115-119
Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.115

Glucan-immunostimulant, adjuvant, potential drug

Vaclav Vetvicka

Vaclav Vetvicka, Department of Pathology, University of Louisville, Louisville, KY 40202, United States

Author contributions: Vetvicka V solely contributed to this paper.

Correspondence to: Vaclav Vetvicka, PhD, Professor, Department of Pathology, University of Louisville, 511 S. Floyd, Louisville, KY 40202, United States. vaclav.vetvicka@louisville.edu

Telephone: +1-502-8521612 Fax: +1-502-8521177

Received: June 23, 2010
Revised: September 15, 2010
Accepted: September 22, 2010
Published online: February 10, 2011

Core Tip